Literature DB >> 17318427

Genomic sequence of an antigenic variant Newcastle disease virus isolated in Korea.

Sun-Hee Cho1, Sun-Joong Kim, Hyuk-Joon Kwon.   

Abstract

In Korea, extensive Newcastle disease (ND) vaccine programs have been implemented, but ND outbreaks continue to occur occasionally, even in well-vaccinated farms. KBNP-4152 is a virulent ND virus, which has been isolated from vaccinated chickens in Korea. In this study, we conducted a comparison of the antigenicity of KBNP-4152 with that of a vaccine strain, La Sota, via virus-neutralization (VN) and cross haemagglutination-inhibition (HI) tests, and analyzed the genomic sequences. The antigenicity of KBNP-4152 was distinct from La Sota, and the expected genome size was 15,192 nt, as was the case with other recent virulent ND viruses analyzed. Based on the partial F gene, the strain was phylogenetically classified into the VIId genotype, but was distinct from other VII viruses due to amino acid changes at (E347K) and proximal to (M354K), the major linear epitope of HN, as well as relatively low amino acid similarity of the V protein, and a truncated W protein (203 aa vs. 227 aa). Therefore, KBNP-4152 is unique among genotype VII.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318427     DOI: 10.1007/s11262-007-0078-z

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  45 in total

1.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies.

Authors:  P H Russell; D J Alexander
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan.

Authors:  L Yu; Z Wang; Y Jiang; L Chang; J Kwang
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Characterization of Newcastle disease viruses isolated from chickens and ducks in Tamilnadu, India.

Authors:  P Roy; A T Venugopalan; R Manvell
Journal:  Vet Res Commun       Date:  2000-03       Impact factor: 2.459

5.  Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death.

Authors:  Elizabeth K Wansley; Griffith D Parks
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Newcastle disease virus V protein is a determinant of host range restriction.

Authors:  Man-Seong Park; Adolfo García-Sastre; Jerome F Cros; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity.

Authors:  M S Collins; J B Bashiruddin; D J Alexander
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication.

Authors:  Jean-Patrick Parisien; Joe F Lau; Curt M Horvath
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.

Authors:  B Gotoh; T Sakaguchi; K Nishikawa; N M Inocencio; M Hamaguchi; T Toyoda; Y Nagai
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

10.  Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein.

Authors:  Tatiana L Bousse; Garry Taylor; Sateesh Krishnamurthy; Allen Portner; Siba K Samal; Toru Takimoto
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  22 in total

1.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

2.  Designing a Novel Recombinant HN Protein with Multi Neutralizing Antigenic Sites and Auto Tag Removal Ability Based on NDV-VIIj for Diagnosis and Vaccination Application.

Authors:  Vafa Mayahi; Majid Esmaelizad; Naser Harzandi
Journal:  Indian J Microbiol       Date:  2018-04-25       Impact factor: 2.461

3.  Genomic and biological characteristics of Avian Orthoavulavirus-1 strains isolated from multiple wild birds and backyard chickens in Pakistan.

Authors:  Abdul Wajid; Vafa Mayahi; Renfu Yin; Quratul Ain; Ayesha Mohiuddin; Farah Khalid; Asif Rehim; Abdul Manan; Muqadas Baksh
Journal:  Trop Anim Health Prod       Date:  2021-01-07       Impact factor: 1.559

4.  Molecular and biological characterization of the immunological potency of Newcastle disease virus oil emulsion-inactivated vaccines prepared from field isolate obtained from vaccinated chickens outbreak.

Authors:  Mohammed Ismail Hassan; Mohamed Wael Abd El-Azeem; Abdullah Selim; Serageldeen Sultan
Journal:  Braz J Microbiol       Date:  2019-12-16       Impact factor: 2.476

5.  Characterization of complete genome sequence of genotype VI and VII velogenic Newcastle disease virus from Japan.

Authors:  Dennis V Umali; Hiroshi Ito; Kazutoshi Shirota; Hiromitsu Katoh; Toshihiro Ito
Journal:  Virus Genes       Date:  2014-05-01       Impact factor: 2.332

6.  Artificial recombination may influence the evolutionary analysis of Newcastle disease virus.

Authors:  Qingqing Song; Yongzhong Cao; Qun Li; Min Gu; Lei Zhong; Shunlin Hu; Hongquan Wan; Xiufan Liu
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

7.  The effect of vaccination on the evolution and population dynamics of avian paramyxovirus-1.

Authors:  Yee Ling Chong; Abinash Padhi; Peter J Hudson; Mary Poss
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

8.  Newcastle disease virus in Madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV.

Authors:  Olivier F Maminiaina; Patricia Gil; François-Xavier Briand; Emmanuel Albina; Djénéba Keita; Harentsoaniaina Rasamoelina Andriamanivo; Véronique Chevalier; Renaud Lancelot; Dominique Martinez; R Rakotondravao; Jean-Joseph Rajaonarison; M Koko; Abel A Andriantsimahavandy; Véronique Jestin; Renata Servan de Almeida
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

9.  Variation of a newcastle disease virus hemagglutinin-neuraminidase linear epitope.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Sun-Joong Kim
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

10.  Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain.

Authors:  Woo-Jin Jeon; Eun-Kyoung Lee; Young-Jeong Lee; Ok-Mi Jeong; Yong-Joo Kim; Jun-Hun Kwon; Kang-Seuk Choi
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.